Polaris AI Pharma Corp. (KOSDAQ:041910)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Other Product	34.00B
Other Product Growth	2.03%
Peptic Ulcer Medication	13.49B
Peptic Ulcer Medication Growth	-12.91%
Diabetic Medication	3.93B
Diabetic Medication Growth	-7.91%
Goods	3.28B
Goods Growth	-27.90%
Antipyretic, Analgesic and Anti-inflammatory	2.20B
Antipyretic, Analgesic and Anti-inflammatory Growth	-5.14%
Other Central Nervous System Drugs	1.31B
Other Central Nervous System Drugs Growth	-50.98%
True Economy	1.17B
True Economy Growth	125.12%
Other	229.00M
Other Growth	31.47%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
South Korea	47.33B
South Korea Growth	-6.03%
Overseas	12.27B
Overseas Growth	-11.38%